potential to provide so called “broader value” benefiting healthcare systems, society, and the economy. We analysed the status of incorporating broader value elements in HTA decision-making in the Asia-Pacific region, which faces socio-economic challenges due to an ageing population and rising chronic disease burden and healthcare capacity challenges. The report provides a framework and recommendations to improve broader value recognition and promote innovation, addressing both clinical and societal needs.
Our spotlight publication provides an overview of value-based approaches to HTA and pricing of health innovations. It describes how a value-based approach can deliver a "triple win," where patients gain access to effective technologies, healthcare systems remain financially sustainable, the full socio-economic value of innovation is well-understood, and can be rewarded appropriately.
Both OHE publications highlight the need for stakeholder collaboration for policy change. Increased collaboration in HTA decision-making is also the theme of our spotlight Insight, addressing how collaborative initiatives can help overcome challenges.
Lastly, in OHE’s "Around the World in HTAs" series, we visit Canada, where the CDA-AMC explicitly considers five ‘domains of value’: clinical value, unmet clinical need, social and ethical considerations, economic considerations, and impacts on health systems.
OHE remains committed to continuing research and debate on the “value” of health technologies. Stay tuned for upcoming panels, presentations, and posters by OHE at ISPOR and IHEA conferences 2025 on incorporating broader value elements in development and HTA decision-making.
